DNA BYTES · Fusion Genomics produces the World’s First ... Fusion Genomics. The DNA Diagnosis...
2
DNA BYTES Fusion is pleased to welcome Akmal Jameel to our man- agement team as the new CFO. Akmal brings a wealth of experience in financial management of start-ups. In This Issue Milestone Achieved Share Price Increase World’s First Child- hood Cancer NGS Test Introducing Our New CFO ONETest tm for Influ- enza Fusion Genomics produces the World’s First Childhood Cancer NGS Test Funding Milestone Exceeded! Fusion is pleased to announce that our first round of seed funding is complete. We sought C$ 500K and actually received C$ 580K, eighty thousand more than we were asking for. Thanks to all our investors who helped us reach and exceed this goal! Share Values Increase 3-fold! The C$ 580K was raised at C$ 0.50 per share, a 3-fold increase from our initial Friends and Family round last year, and a 2-fold increase from our Extended Fam- ily and Friends Round. Interim Funding Round In our next round of funding we will be seeking C$ 650K (US$ 500K) at C$ 1.30 (US$ 1.00) per share. Full Funding Round for US$ 2.3 - 3.0M Our next full funding round will seek ~ US$ 3M. World’s First Childhood Cancer NGS Test Fusion’s ChildSeq-Sarcoma ONETest tm is the world’s first test for childhood can- cers that uses Next Generation Sequencing to identify the gene fusion responsible for causing the cancer in a child with a sarcoma. Fusion Genomics Corporation September 2015
Transcript of DNA BYTES · Fusion Genomics produces the World’s First ... Fusion Genomics. The DNA Diagnosis...
DNA BYTES
Fusion is pleased to welcome
Akmal Jameel to our man-
agement team as the new
CFO. Akmal brings a wealth
of experience in financial
management of start-ups.
In This Issue
Milestone Achieved
Share Price Increase
World’s First Child-
hood Cancer NGS
Test
Introducing Our New
CFO
ONETesttm for Influ-
enza Fusion Genomics produces the World’s First Childhood Cancer NGS Test
Funding Milestone Exceeded! Fusion is pleased to announce that our first round of seed funding is complete.
We sought C$ 500K and actually received C$ 580K, eighty thousand more than
we were asking for. Thanks to all our investors who helped us reach and exceed
this goal!
Share Values Increase 3-fold! The C$ 580K was raised at C$ 0.50 per share, a 3-fold increase from our initial
Friends and Family round last year, and a 2-fold increase from our Extended Fam-
ily and Friends Round.
Interim Funding Round
In our next round of funding we will be seeking C$ 650K (US$ 500K) at C$ 1.30
(US$ 1.00) per share.
Full Funding Round for US$ 2.3 - 3.0M
Our next full funding round will seek ~ US$ 3M.
World’s First Childhood Cancer NGS Test Fusion’s ChildSeq-Sarcoma ONETesttm is the world’s first test for childhood can-
cers that uses Next Generation Sequencing to identify the gene fusion responsible
for causing the cancer in a child with a sarcoma.
Fusion Genomics Corporation September 2015
Contact Us
Give us a call for more in-
formation about our ser-
vices and products
Fusion Genomics
8999 Nelson Way
Burnaby BC, V5A 4W9
Canada
(604) 428-7701
Visit us on the web at
www.fusiongenomics.com
ONETesttm
for Influenza Strains In order to stop the spread of influenza and prevent Infuenza outbreaks and pan-
demics, clinicians need to know which strain is infecting humans. Once the strain
is known, facilities can produce the necessary vaccine and it can be administered
to uninfected people to help boost their immunity to the flu.
We are in the final stages of developing a ONETesttm kit that tests for all strains of
human influenza virus and requires only a simple non-invasive nasopharyngeal
swab to obtain the patient sample needed for library construction, target-capture
and Next Generation Sequencing. Results are achieved in approximately 48
hours. A manuscript describing the entire process is being prepared for publica-
tion within the next few months.
ONETesttm results show this patient is H1N1
Fusion Genomics, Inc.
8999 Nelson Way
Burnaby BC, V5A 4W9
Fusion Genomics
8999 Nelson Way
PLACE STAMP HERE
Fusion Genomics. The DNA Diagnosis Company
Influenza Subtypes
0
2000
4000
6000
H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14 H15 H16 BH
0
4000
8000
12000
16000
N1 N2 N3 N4 N5 N6 N7 N8 N9 BN
